Concepedia

Drug monitoring of etoposide (VP16-213)

K. -H. Pfl�ger, Lothar Schmidt, Mark Merkel, H. Jungclas, K. Havemann

Cancer Chemotherapy and Pharmacology · 1987 · 28 citations · 17 references

DOI

Concepts

References

17

Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients.

Kenneth R. Hande, P J Wedlund, Richard M. Noone et al. · PubMed · 1984 · 150 citations

, , +15

Pharmacokinetics of VP16-213 given by different administration methods

Maurizio D’Incalci, P. Farina, Cristiana Sessa et al. · Cancer Chemotherapy and Pharmacology · 1982 · 120 citations

, , +9

Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivatives

Larry M. Allen, Patrick J. Creaven · European Journal of Cancer (1965) · 1975 · 109 citations

, , +7

Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancer

WilliamE. Evans, J A Sinkule, WilliamR. Crom et al. · Cancer Chemotherapy and Pharmacology · 1982 · 107 citations

, , +9

Bioavailability and pharmacokinetics of etoposide (VP-16).

PubMed · 1985 · 86 citations

, , +8